Waiting for the next wave...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Google this article - I cannot copy it - Protected by Copyright law:
Elite-Pharma-Eyes-on-Troxyca-but-Pfizer-blocking-generic-release
You will get it.... Pfizer has 3.5 years of exclusivity where Notralxone based products cannot be marketed. This article is from 2018 - do the math....
Any announcement with Pfizer will stop the manipulation. It would give ce us the necessary volume to start the climb.
We would need also more buzz.
I never felt so sure elite will make it big time.
Going for the third mil.
Black Friday deal!!! Thanks Nasrat!!!
I conveyed this information to Nasrat to separate channels...
better late than never
I never said Nasrat had quick reflexes...
This could be the trigger for Pfizer/Elite partnership
Old wolf knows what he is doing...
https://www.reuters.com/article/us-pfizer-fda-idUSKCN0YS1P9
Nasrat is selling his house - moving to rental - buying more Elite shares...
$9.5 million in working capital
8.5 million in revenue!!!!!
Hi fellow investors - here are my questions to Dianne for the teleconference:
1) Could Elite finalize SequestOX FDA approval and partner with a company who actively sells Opioids, sell the the rights of SequestOx while keeping the manufacturing in-house?
2) Has Elite tried to propose a manufacturing partnership with Merck and/or Pfizer on their latest COVID pills, Tablets and capsules?
3) Can Elite fill the Pipeline page with Product code names so investors can see what is the depth of the R&D and Elite plans (without providing sensitive information that could help the competition)? We believe that the lack of information on pipeline is not helping the stock price.
4) Can you please provide the results of the strategic partner change (move to EPIC), and the impact of KVK being banned to sell bariatrics by the FDA?
5) Can you please con firm 2022 4 drugs?
6) Can you please confirm NASDAQ in 2022?
7) Can you please provide an estimate at what the Stock price should be based on other companies in the same space?
Isradipine and Trimipramine are with our partner, Epic. These 2 products are interesting because they have limited competition. Each one has only one competitor in the market. Glenmark, our previous partner, was not able to give them the attention we believe they deserve. We expect Epic to be more effective in the marketing of Isradipine and Trimipramine. And let me make a comment here.
It is about market penetration when you have 16, 20 players. But when you're the only one in the market or there's 2, it's about the price adjustment. And when Actavis were selling these products, we were making millions. Glenmark was selling them at a small little margin above cost, and that is not the way to handle it. That's why we reverted to Epic, hoping that they know how to sell these products.
Kvk effect + epic effect = $10 million plus
No I think we are partnering with Merck on the Vaccine Killer - Tamiflu for Covid...
found something at the bottom:
LANNETT COMPANY, INC.
NET SALES BY MEDICAL INDICATION
Three months ended
($ in thousands) September 30,
Medical Indication 2021 2020
Analgesic $ 5,314 $ 3,120
Anti-Psychosis 3,715 13,028
Cardiovascular 14,100 19,714
Central Nervous System 22,785 22,525
Endocrinology 7,845 3,233
Gastrointestinal 15,240 17,100
Infectious Disease 12,515 21,932
Migraine 4,685 9,690
Respiratory/Allergy/Cough/Cold 3,114 1,426
Urinary 1,176 1,458
Other 9,176 7,634
Contract Manufacturing revenue 1,860 5,619
Net Sales $ 101,525 $ 126,479
Guys - I searched for the word CNS then Adderall and both returned 0 items in the search - Bubba show us the info !!!
We could be in for a big positive surprize this quarter - more bariatrics sales and more adderall sales if we got 1 or 2 more contracts...
I checked their SEC filing, there is no detail about the product lines and sales this time.
Previous Sec filings had a table with the totals per line of Products (CNS etc...).
No one can say if they sold more Adderall last quarter - sorry...
7:38 am today
On tdameritrade benziga released $2.50 versus $2.47.
Lannett beats concensus. Will check sec filing.
This quarter LCI will report on 11/2 like two weeks before Elite - we may have a big surprise in the Adderall space...
I also believe next month will be a big surprise in sales - we will reach new highs
Is Godzilla CNS 100% owned by Elite? Where do we have that written?
I do not recall a lot of reporting on that one for a while.. Is it still alive?
Thanks
Sent an Email to Dianne (PR), and formally requested that the page for Pipeline be populated with the drugs we are manufacturing.
Wrote that no serious investor would put money in Elite (except us who have been in for years and are trapped) without seeing a pipeline and list of current drugs manufactured.
We shall see
Is that all you can remember from today's trading?
LOL
4.4 Million shares traded.... long time no see
Nice finish...
Numbers are in for september - great quarter I hear...
There is a buying in teh deep happening... the more buyers buy, the lower the price lol
Disgusting...
I believe the stars will align soon and we will see a huge bump in revenue that will create a buy wave not be stoppable by the manipulators...
my 2 cents -
Yea reliable profitable companies. Better if they have been dha approved for a decade too. That is a proof.
Nasrat. Save the world with merck
We just need a PR saying that Nasrat thinks of partnering with Merck lol.
If elite could help Merck produce these new Covid Tami packs!!!
Even at cost plus 10%.
Merck will need all the help possible to produce.
The offices from the 2 companies are close to each other. Perfect match.
Can ELITE buy back 200 million shares with the 8 Million in cash they have or do they have to buy in the open market and end up with half of that?
With KVK Bariatrics out of the way, we have a potential to break 10 Million in sales this quarter.
If Lanett closes a few good contracts with Adderall XR, we could see $15 Million this quarter.
Several nice options and potential big surprises